Machine-Learning (“ML”) (sometimes referred to as artificial intelligence or “AI”) has experienced a renaissance over the past five years thanks to a combination of big data, fast processors, and new algorithms. ML is all around us; from stock trading to autonomous vehicles, ML is already transforming a wide range of industries by finding patterns in massive datasets and delivering actionable intelligence.
Medxtractor Corp. (CSE: MXT) (OTC: MXTTF) is leveraging ML, through its SHAMAN program, to predict probable mental illnesses, and the potential effects of various drugs, including psychedelics, on those illnesses. SHAMAN is a diagnostic tool with an over-arching goal of reducing misdiagnosis rates to increase the efficiency of the overall health system.
We take a look at why improved diagnostics are necessary in mental health and how SHAMAN is well-positioned to address the industry’s shortcomings through ML. |